STOCK TITAN

Intra-Cellular Therapies to Present at the 40th Annual J.P. Morgan Healthcare Conference

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences
Rhea-AI Summary

Intra-Cellular Therapies (ITCI), a biopharmaceutical company focused on treatments for central nervous system disorders, announced that CEO Sharon Mates, Ph.D., will present at the 40th Annual J.P. Morgan Healthcare Conference. The presentation is scheduled for January 10, 2022, at 7:30 AM ET. Investors can access the live and archived webcast through the company's website under the 'Events & Presentations' section. Intra-Cellular Therapies develops innovative therapies based on groundbreaking research to treat complex psychiatric and neurologic conditions.

Positive
  • None.
Negative
  • None.

NEW YORK, Jan. 03, 2022 (GLOBE NEWSWIRE) -- Intra-Cellular Therapies, Inc. (Nasdaq: ITCI), a biopharmaceutical company focused on the development and commercialization of therapeutics for central nervous system (CNS) disorders, today announced that Sharon Mates, Ph.D., Chief Executive Officer and Chairman, is scheduled to present at the 40th Annual J.P. Morgan Healthcare Conference on Monday, January 10, 2022 at 7:30 am ET.

The live and archived webcast can be accessed under "Events & Presentations" in the Investor Relations section of the Company's website at www.intracellulartherapies.com. Please log in approximately 5-10 minutes prior to the event to register and to download and install any necessary software.

About Intra-Cellular Therapies

Intra-Cellular Therapies is a biopharmaceutical company founded on Nobel prize-winning research that allows us to understand how therapies affect the inner-workings of cells in the body. The company leverages this intracellular approach to develop innovative treatments for people living with complex psychiatric and neurologic diseases. For more information, please visit www.intracellulartherapies.com.

Contact:

Intra-Cellular Therapies, Inc.
Juan Sanchez, M.D.
Vice President, Corporate Communications and Investor Relations
646-440-9333

Burns McClellan, Inc.
Lisa Burns
cradinovic@burnsmc.com
212-213-0006


FAQ

When is Sharon Mates presenting at the J.P. Morgan Healthcare Conference for ITCI?

Sharon Mates is scheduled to present on January 10, 2022, at 7:30 AM ET.

Where can I watch the ITCI presentation from the J.P. Morgan Healthcare Conference?

The presentation can be accessed live and archived on the Intra-Cellular Therapies website under 'Events & Presentations.'

What does Intra-Cellular Therapies focus on?

Intra-Cellular Therapies focuses on developing therapeutics for central nervous system disorders.

Who is the CEO of Intra-Cellular Therapies?

The CEO of Intra-Cellular Therapies is Sharon Mates, Ph.D.

What is the stock symbol for Intra-Cellular Therapies?

The stock symbol for Intra-Cellular Therapies is ITCI.

Intra-Cellular Therapies Inc.

NASDAQ:ITCI

ITCI Rankings

ITCI Latest News

ITCI Stock Data

9.07B
106.02M
2.33%
98.95%
2.28%
Drug Manufacturers - Specialty & Generic
Pharmaceutical Preparations
Link
United States of America
BEDMINSTER